STARTON THERAPEUTICS

starton-therapeutics-logo

Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies.

#SimilarOrganizations #People #Website #More

STARTON THERAPEUTICS

Social Links:

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2017-01-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.startontx.com

Total Employee:
11+

Status:
Active

Contact:
+1 800 449 5405

Email Addresses:
[email protected]

Total Funding:
8.53 M USD

Technology used in webpage:
Domain Not Resolving


Similar Organizations

aspen-neuroscience-logo

Aspen Neuroscience

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

carisma-therapeutics-logo

Carisma Therapeutics

Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.

Current Employees Featured

pedro-lichtinger_image

Pedro Lichtinger
Pedro Lichtinger Chairman & CEO @ Starton Therapeutics
Chairman & CEO
2017-03-01

Founder


pedro-lichtinger_image

Pedro Lichtinger

Official Site Inspections

http://www.startontx.com Semrush global rank: 9.05 M Semrush visits lastest month: 445

Unable to get host informations!!!

Loading ...

More informations about "Starton Therapeutics"

About - Starton Therapeutics

Determined to address unmet medical needs The FDA defines unmet medical need for cancer as a serious condition that is not adequately treated by current therapies. This could include conditions that are rare, have few treatment …See details»

Starton Therapeutics Contracts Global Clinical Research …

Jul 10, 2023 Paramus, NJ – Starton Therapeutics Inc. (“Starton” or “the Company”), a clinical-stage biotechnology company focused on transforming standard-of-care therapies with …See details»

Starton Therapeutics Announces Enrollment Completion for

Apr 25, 2024 Starton’s proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. To learn more, …See details»

Starton Therapeutics’ Chief Executive Officer Chosen as

Sep 24, 2024 “As someone who has dedicated his career towards advancing new treatments for cancer, I am inspired by the Foundation’s success in expanding patient access to potentially …See details»

Starton Therapeutics - Crunchbase Company Profile

Starton Therapeutics is a biotechnology company that focuses on transforming the standard of care in therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting.See details»

Starton Therapeutics to Present at BIO CEO & Investor ... - BioSpace

Feb 23, 2024 Starton Therapeutics Inc. (“Starton” or the “Company”) today announced that Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics, will present and host one-on-one meetings at the BIO CEO & Investor Conference being held in New York City, February 26-27, 2024.See details»

Starton Therapeutics - LinkedIn

Starton Therapeutics | 1,201 followers on LinkedIn. Transforming therapies with proprietary dermal technology, so people with cancer can live better, longer. | Starton Therapeutics is a clinical ...See details»

Starton Therapeutics to Present at Biotech Showcase 2025

PARAMUS, N.J., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»

Starton Therapeutics to Present at BIO CEO & Investor

Feb 23, 2024 To learn more, visit www.startontx.com. Forward looking statements. This press release contains statements that constitute “forward-looking statements.” Forward-looking statements are subject ...See details»

Starton Therapeutics Announces Enrollment Completion for

Apr 25, 2024 To learn more, visit www.startontx.com. Forward Looking Statements All statements other than statements of historical facts included in this press release, including, …See details»

Starton Therapeutics’ Chief Executive Officer Chosen as 2024 …

Sep 24, 2024 PARAMUS, N.J., – Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary …See details»

Starton Therapeutics Announces Enrollment Completion for STAR …

Apr 25, 2024 Starton Therapeutics. Phase 1b data in the first 50% of patients reflect the responses seen in animals and may suggest superiority in both safety and efficacy when …See details»

Starton Therapeutics’ Chief Executive Officer Chosen as ... - BioSpace

PARAMUS, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical-stage biotechnology company transforming standard-of-care …See details»

Starton Therapeutics - VentureRadar

"A clinical-stage biotechnology company focused on transforming standard of care therapeutics. Starton uses proven continuous delivery technology to obtain new indications or develop on …See details»

Starton Therapeutics’ Chief Executive Officer ... - Markets Insider

Sep 24, 2024 “As someone who has dedicated his career towards advancing new treatments for cancer, I am inspired by the Foundation’s success in expanding patient access to potentially …See details»

Starton Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...

Contact [email protected] . Phase 1 ASCO Phase 2 Clinical Result. 100 Deals associated with Starton Therapeutics, Inc. Login to view more data. 100 Translational Medicine …See details»

Starton Therapeutics Announces the Launch of STARSILON a

Jan 2, 2024 To learn more, visit www.startontx.com. Forward-looking statements. This press release contains statements that constitute “forward-looking statements.” Forward-looking …See details»

Starton Therapeutics Announces Approval to Proceed with Final …

May 23, 2022 Starton Therapeutics, Inc. Independent safety review approved dose escalation and initiation of third and final dosing cohort. STAR-LLD well tolerated in all subjects dosed to …See details»

Starton Therapeutics, Inc. (Starton Therapeutics, Inc.) - 药物管线_ …

3 days ago To learn more, visit www.startontx.com. Forward Looking Statements All statements other than statements of historical facts included in this press release, including, without …See details»

Governance - Starton Therapeutics

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas pulvinar gravida diam, sed laoreet mauris commodo vel. Maecenas sit amet purus turpis. In sollicitudin massa risus, eget …See details»

linkstock.net © 2022. All rights reserved